微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.95% | -51.95% | -81.87% | 24/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 16.27% | -25.81% | 18.85% | 7/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 13.69% | -15.18% | 62.59% | 9/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 8.42% | -18.88% | 37.13% | 11/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 6.14% | 5.86% | -72% | 6/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 21.93% | 7.08% | 35.87% | 4/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 16.14% | -2.06% | 55.49% | 6/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 10.38% | 9.96% | 78.97% | 10/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 5.8% | -6% | -71.68% | 11/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 20.48% | 10.52% | 24.27% | 4/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 16.48% | 6.53% | 74.58% | 5/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 9.44% | -4.74% | 53% | 6/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 6.17% | 12.18% | -66.7% | 2/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 18.53% | -3.59% | 19.78% | 4/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 15.47% | -2.83% | 56.1% | 5/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 9.91% | -8.41% | 80.18% | 4/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 5.5% | -24.97% | -71.38% | 7/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 19.22% | -29.93% | 20.73% | 3/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 15.92% | -30.93% | 47.13% | 3/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 10.82% | -31.48% | 47.61% | 3/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 7.33% | -17.92% | -73.28% | 1/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 27.43% | -16.35% | 19% | 1/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 23.05% | -16.33% | 45.98% | 1/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 15.79% | -10.39% | 76.82% | 1/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 8.93% | -11.32% | -72.77% | 2/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 32.79% | 9.34% | 19.02% | 1/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 27.55% | 13.84% | 56.36% | 1/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 17.62% | 20.36% | 74.98% | 1/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 10.07% | 31.81% | -66.42% | 1/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 29.99% | 3.74% | 23.93% | 3/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 24.2% | 6.19% | 65.3% | 1/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 14.64% | -2.2% | 91.62% | 1/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 7.64% | 1.33% | -73.57% | 1/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 28.91% | 8.44% | 26.85% | 2/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 22.79% | 6.64% | 52.24% | 2/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 14.97% | 13.41% | 98.54% | 2/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 7.54% | 12.2% | -71.72% | 3/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 26.66% | 10.53% | 24.75% | 5/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 21.37% | 6.9% | 61.89% | 1/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 13.2% | 2.4% | 96.43% | 3/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 6.72% | -12.84% | -72.14% | 4/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |